What's Going On With CVS Health Stock?
What's Going On With CVS Health Stock?
CVS Health Corp (NYSE:CVS) shares are trading marginally lower by 1.52% to $56.97 during Friday's session. The stock has been muted since the company earlier this week reported worse-than-expected second-quarter sales results and cut its FY24 adjusted EPS guidance below estimates.
CVS健康公司（NYSE：CVS）股票在週五的交易中輕微下跌1.52％至56.97美元。本週早些時候，該公司公佈了二季度銷售業績低於預期並將其FY24調整後的每股收益指引下調至預期以下的業績，從那以後股價一直很平靜。
What Happened?
發生了什麼？
CVS posted sales of $91.23 billion, slightly below the $91.51 billion consensus, with total revenues up 2.6%, driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments, though offset by a decline in the Health Services segment.
CVS的銷售額爲912.3億美元，略低於915.1億美元的共識，總收入增長2.6％，受到其醫療保健福利和藥房及消費者健康業務增長的推動，雖然受到醫療服務業務下降的抵消。
Adjusted EPS was $1.83, down from $2.21 last year but above the $1.73 consensus. Operating income fell 16.4% to $3.74 billion. The Health Care Benefits segment's revenues grew by 21.4%, while the Health Services segment's revenues dropped by 8.8%.
調整後的每股收益爲1.83美元，去年爲2.21美元，但高於1.73美元的共識。營業收入下降16.4％至37.4億美元。醫療保健福利業務收入增長了21.4％，而醫療服務業務收入下降了8.8％。
Leadership changes were announced, with CEO Karen Lynch taking direct control of the Health Care Benefits segment. CVS revised its 2024 adjusted EPS guidance to $6.40-$6.65, down from at least $7.00, and lowered its cash flow guidance due to continued pressure in the Health Care Benefits segment.
宣佈了領導層變動，首席執行官Karen Lynch直接掌管醫療保健福利業務。CVS將其2024年調整後的每股收益指引修訂爲6.40-6.65美元，低於至少7.00美元，並由於醫療保健福利業務的持續壓力而降低了其現金流指引。
Read Also: Boeing's New CEO Kelly Ortberg Shifts Base To Seattle Amid Airplane-Maker's Safety Crisis
讀取也可以：波音新CEO凱利·奧特伯格在飛機制造商的安全危機中轉移到西雅圖總部
Is CVS A Good Stock To Buy?
CVS是一隻值得購買的好股票嗎？
Wall Street analysts view CVS Health on the whole as a Neutral, given the history of coverage over the past three months. Lisa Gill from JP Morgan in CVS Health is the most bearish, expecting a 14.85% fall in the stock in the coming year.
華爾街分析師普遍認爲CVS Health是中立的，因爲過去三個月的覆蓋歷史。摩根大通的Lisa Gill是CVS Health中最看淡的，預計該股在未來一年將下跌14.85％。
But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past 3 months, CVS Health rose 2.65%, which indicates that opinion improved on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which rose 2.6% over the past year.
但是，觀察整個市場對該股票的看法，您可以參考歷史價格走勢，以了解投資者對該股票持有的任何強烈觀點。在過去的3個月中，CVS健康公司上漲了2.65％，這表明基於其股價或營業收入等基本面，市場對其業務及可持續性的看法有所改善。
A complete overview of how Wall Street views individual stocks is available here, while real time updates on the latest analyst actions will be delivered via Benzinga PRO. Try it for free.
可以在此處獲得有關華爾街如何看待個股的完整概述，而最新分析師行動的實時更新將通過Benzinga PRO提供。立即免費試用。
CVS has a 52-week high of $83.25 and a 52-week low of $52.77.
CVS的52周高點爲83.25美元，52周低點爲52.77美元。